Inhibiting peptides derived from triggering receptor expressed on myeloid cells-1 (TREM-1) TREM-like transcript 1 (TLT-1) for treatment of cardiovascular diseases
US9657081B2 · kind B2 · utility
3Cited by
4References
6Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 9, 2013 |
| Grant date | May 23, 2017 |
| Priority date | — |
| Expiry date | Nov 1, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P9/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a peptide comprising at least 6 consecutive amino acid selected from the amino acid sequence SEQ ID NO: 2 and a function-conservative variant. The invention also relates to a peptide comprising at least 6 consecutive amino acid selected from the amino acid sequence SEQ ID NO: 1 or SEQ ID NO: 2 and a function-conservative variant for use in the treatment of a cardiovascular disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.